Related Experiment Video
Updated: Jun 20, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Optimal management of hypertension in patients with ischemic heart disease
Debabrata Mukherjee1, Charles L Campbell
1Gill Heart Institute and the Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky 40536-0200, USA. Mukherjee@uky.edu
Insights
Managing hypertension in patients with ischemic heart disease (IHD) involves balancing oxygen supply and demand. This review guides the use of antihypertensive drugs for IHD, acute coronary syndromes, and heart failure, emphasizing blood pressure control.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Hypertension is a significant risk factor for cardiovascular disease (CVD), including myocardial infarction (MI) and stroke.
- A strong association exists between hypertension and ischemic heart disease (IHD).
- Patients with hypertension and heart failure represent a high-risk group requiring careful management.
Purpose of the Study:
- To review current guidelines on antihypertensive drug selection for patients with established IHD, acute coronary syndromes, MI, and heart failure.
- To identify antihypertensive agents beneficial for these patient populations.
- To highlight drug classes that should be avoided in hypertensive patients with IHD and heart failure.
Main Methods:
- Review of current clinical guidelines.
- Analysis of evidence supporting the use and avoidance of specific antihypertensive drug classes.
- Synthesis of recommendations for managing hypertension in specific cardiovascular conditions.
Main Results:
- Specific antihypertensive drug classes are recommended for patients with IHD, acute coronary syndromes, MI, and heart failure.
- Certain antihypertensive agents should be avoided in these high-risk patient groups.
- Effective blood pressure control is the primary goal, regardless of the specific agent used.
Conclusions:
- Appropriate selection of antihypertensive agents is crucial for managing patients with IHD and heart failure.
- Adherence to current guidelines ensures optimal treatment outcomes.
- Achieving adequate blood pressure control is paramount in reducing cardiovascular adverse events.
Abstract:
Epidemiological studies suggest a strong association between hypertension and ischemic heart disease (IHD), and hypertension is a major independent risk factor for the development of cardiovascular disease (CVD) including myocardial infarction (MI) and stroke. The primary objective of the management of hypertension in patients with IHD is modification of the balance between myocardial oxygen supply and demand to improve symptoms and reduce future cardiovascular adverse events. Patients with hypertension and heart failure constitute another important cohort in this high risk group. While several classes of antihypertensive agents have been shown to be beneficial in treating these patients, there are also several classes of drugs that should be avoided when treating hypertension in patients with IHD and heart failure. This review discusses which antihypertensive drugs should be used in patients who have established IHD with angina pectoris, in those with acute coronary syndromes and MI, and in those with heart failure. These recommendations are based on current guidelines. Finally, although there may be some differences in cardiovascular risk reduction among antihypertensive agents, the most important objective in hypertension management is to adequately control blood pressure irrespective of the agent used.
Related Concept Videos
Atherosclerosis III: Management
Angina IV: Management
Heart Failure V: Medical Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System